Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+94.7%
5Y CAGR+135.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+94.7%/yr
Annual compound
5Y CAGR
+135.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
72.5x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $38.58M | +62.0% |
| 2024 | $23.82M | +66.6% |
| 2023 | $14.30M | +173.4% |
| 2022 | $5.23M | +116.3% |
| 2021 | $2.42M | +354.3% |
| 2020 | $532000.00 | - |